General Information of Drug (ID: DM8FD3Z)

Drug Name
HG-9-91-01 Drug Info
Synonyms HY-15776
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
78357808
ChEBI ID
CHEBI:133818
TTD Drug ID
DM8FD3Z

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Investigative Drug(s)
Clinical Trial Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
PMID24900538C2c DM5PATM Discovery agent N.A. Investigative [2]
Drug Name Drug ID Indication ICD 11 Highest Status REF
GRN-300 DMISPYI Ovarian cancer 2C73 Phase 1 [3]
Drug(s) Targeting SIK family kinase 3 (SIK3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
GRN-300 DMISPYI Ovarian cancer 2C73 Phase 1 [3]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Salt-inducible kinase 1 (SIK1) TT1H6LC SIK1_HUMAN Inhibitor [1]
Salt-inducible kinase 2 (SIK2) TTCUGZR SIK2_HUMAN Inhibitor [1]
SIK family kinase 3 (SIK3) TTW6L4V SIK3_HUMAN Inhibitor [1]

References

1 Phosphorylation of CRTC3 by the salt-inducible kinases controls the interconversion of classically activated and regulatory macrophages. Proc Natl Acad Sci U S A. 2012 Oct 16;109(42):16986-91.
2 Discovery of Disubstituted Imidazo[4,5-b]pyridines and Purines as Potent TrkA Inhibitors. ACS Med Chem Lett. 2012 Jul 26;3(9):705-9.
3 Clinical pipeline report, company report or official report of Green3Bio